Study guide

5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories

AMCB Certified Nurse-Midwife CNM

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care

1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral

2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts

2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy

3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy

3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy

4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss

4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care

5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance

5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion

6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation

6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy

7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair

7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture

8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation

8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications

9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage

9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation

10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health

10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis

11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination

11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes

12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days

12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days

13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization

13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening

14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation

14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral

15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders

15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome

16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause

16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis

17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions

17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking

18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity

18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care

5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories

Key Takeaways Explain This Topic AI

Moderate variability of 6 to 25 bpm is the single most reliable indicator of an intact, well-oxygenated fetal central nervous system without metabolic acidemia.

Early decelerations are gradual and mirror the contraction and reflect benign head compression; late decelerations are gradual with a nadir after the peak and reflect uteroplacental insufficiency; variable decelerations are abrupt and reflect cord compression.

A sinusoidal pattern lasting 20 minutes or more is Category III and signals severe fetal anemia or profound asphyxia.

Category I requires all of a 110 to 160 bpm baseline, moderate variability, and absent late and variable decelerations; early decelerations and accelerations may be present or absent.

Category III is absent variability with recurrent late decelerations, recurrent variable decelerations, or bradycardia, or a sinusoidal pattern.

Last updated: September 2026

Electronic Fetal Monitoring (EFM) Core Parameters (NICHD)

Interpretation of continuous electronic fetal monitoring requires evaluation of five standardized NICHD parameters evaluated over a minimum 10-minute window.

1. Baseline Fetal Heart Rate

The mean FHR rounded to increments of 5 bpm during a 10-minute window, excluding periodic or episodic changes and segments differing by >25 bpm. There must be at least 2 minutes of identifiable baseline.

Normal Range: 110 to 160 bpm .

Fetal Tachycardia (>160 bpm for ≥ 10 minutes):

Etiologies: Intraamniotic infection (chorioamnionitis; most common clinical cause), maternal fever/dehydration, beta-mimetic tocolytics (terbutaline), illicit stimulants (cocaine, methamphetamine), maternal hyperthyroidism, early fetal hypoxemia, or fetal tachyarrhythmias (SVT).

Fetal Bradycardia (<110 bpm for ≥ 10 minutes):

Etiologies: Sudden maternal hypotension (post-epidural sympathetic blockade), umbilical cord prolapse, rapid fetal descent, uterine rupture, placental abruption, or congenital fetal heart block (often associated with maternal systemic lupus erythematosus and anti-Ro/SSA antibodies).

2. Baseline FHR Variability

Fluctuations in the baseline FHR that are irregular in amplitude and frequency, visually quantified as the peak-to-trough amplitude in beats per minute:

Absent: Undetectable amplitude range. Reflects severe fetal central nervous system depression or profound acidemia.

Minimal: Amplitude range detectable but ≤ 5 bpm. Associated with fetal sleep states (normally 20–40 minutes), central nervous system depressant medications (narcotics, magnesium sulfate), extreme prematurity, or developing fetal hypoxia and acidemia.

Moderate: Amplitude range 6 to 25 bpm . This is the single most reliable clinical indicator of an intact, well-oxygenated fetal autonomic nervous system and the absence of cerebral metabolic acidemia (pH > 7.15) at the time of observation.

Marked: Amplitude range >25 bpm. Represents acute autonomic instability, often seen as a compensatory response to acute cord compression or brief hypoxemic stress.

3. Accelerations

A visually apparent, abrupt increase in FHR from onset to peak in <30 seconds:

At ≥ 32 weeks: Peak ≥ 15 bpm above baseline lasting ≥ 15 seconds from onset to return to baseline (15 x 15).

At < 32 weeks: Peak ≥ 10 bpm lasting ≥ 10 seconds (10 x 10).

Prolonged Acceleration: Lasting ≥ 2 minutes but <10 minutes. An acceleration lasting ≥ 10 minutes represents a baseline change .

Clinical Significance: Presence of accelerations reliably excludes fetal metabolic acidemia.

4. Decelerations

Type Morphology & Timing Physiological Etiology Clinical Significance & Action

Early Deceleration Gradual decrease (onset to nadir ≥ 30 sec); nadir coincides exactly with the peak of the contraction ("mirror image") Fetal head compression during descent causes increased intracranial pressure, reduced cerebral blood flow, and vagal nerve activation Benign physiological reflex. Not associated with hypoxia or acidemia. No clinical intervention required.

Late Deceleration Gradual decrease (onset to nadir ≥ 30 sec); nadir occurs after the peak of the contraction; return occurs after contraction ends Uteroplacental insufficiency. Low intervillous pO2 stimulates chemoreceptors, triggering vagal discharge or direct myocardial depression Indicates fetal hypoxemia. Recurrent late decelerations indicate risk of metabolic acidosis. Requires immediate intrauterine resuscitation.

Variable Deceleration Abrupt decrease (onset to nadir <30 sec); drop is ≥ 15 bpm, lasting ≥ 15 sec to <2 min Umbilical cord compression. Occlusion of vein then artery triggers baroreceptor and chemoreceptor vagal responses Common in rupture of membranes. Atypical features (loss of shoulders, slow return, absent variability) signal decompensation. Resuscitation indicated.

Prolonged Deceleration Decrease in FHR ≥ 15 bpm below baseline lasting ≥ 2 minutes but <10 minutes Prolonged cord compression, profound maternal hypotension, uterine rupture, abruption, or tachysystole Acute emergency. If duration exceeds 10 minutes, it is classified as a baseline bradycardia. Immediate resuscitation; prep for delivery.

Sinusoidal Pattern Smooth, undulating sine-wave-like pattern; cycle frequency of 3–5 per minute persisting for ≥ 20 minutes; absent variability Severe fetal anemia (Rh isoimmunization, fetomaternal hemorrhage, ruptured vasa previa, parvovirus B19) or profound asphyxia Category III pattern. High risk of impending fetal death. Requires emergent evaluation, Kleihauer-Betke testing, and immediate operative delivery.

Exam Watchout — Variable Deceleration "Shoulders": A variable deceleration preceded and followed by brief, small accelerations ("shoulders") is a reassuring sign representing intact compensatory baroreceptor reflexes. The loss of shoulders, presence of blunt overshoots, bivariate troughs, or slow, sluggish return to baseline indicates worsening fetal compromise.

The NICHD Three-Tier FHR Interpretation System

The NICHD three-tier system categorizes intrapartum tracings based on their predictive value regarding fetal acid-base status:

Category I: Normal (Predictive of Normal Fetal Acid-Base Status)

Must include ALL of the following criteria:

Baseline rate: 110 to 160 bpm .

Baseline variability: Moderate (6 to 25 bpm) .

Late or variable decelerations: Absent .

Early decelerations: Present or absent.

Accelerations: Present or absent.

Management: Routine intrapartum surveillance; no specific intervention required.

Category II: Indeterminate (Not Predictive of Abnormal Acid-Base Status, but Requires Evaluation)

Includes all tracings that do not meet criteria for Category I or Category III. Examples include:

Tachycardia or bradycardia with continued baseline variability.

Minimal baseline variability, or marked baseline variability.

Absence of induced accelerations after fetal scalp stimulation.

Recurrent variable decelerations with minimal or moderate baseline variability.

Prolonged decelerations (≥ 2 min but <10 min).

Recurrent late decelerations with moderate baseline variability .

Variable decelerations with atypical features (slow return to baseline, "overshoots").

Management: Continuous surveillance, clinical re-evaluation, and execution of the Intrauterine Resuscitation bundle to prevent deterioration into Category III.

Category III: Abnormal (Predictive of Abnormal Fetal Acid-Base Balance at Time of Observation)

Includes EITHER of the following criteria:

Absent baseline FHR variability WITH ANY of the following:

Recurrent late decelerations (occurring with ≥ 50% of contractions).

Recurrent variable decelerations.

Bradycardia (<110 bpm).

Sinusoidal pattern persisting for ≥ 20 minutes.

Management: Immediate, aggressive intrauterine resuscitation. If the tracing fails to resolve rapidly to Category I or II, expeditious delivery (operative vaginal or cesarean delivery) is urgently required.

Loading diagram... NICHD Three-Tier FHR Interpretation & Intrauterine Resuscitation Algorithm